Invention Grant
- Patent Title: Substituted piperidine compound and use thereof
-
Application No.: US18347345Application Date: 2023-07-05
-
Publication No.: US12281073B2Publication Date: 2025-04-22
- Inventor: Tatsuhiko Fujimoto , Kentaro Rikimaru , Koichiro Fukuda , Hiromichi Sugimoto , Takahiro Matsumoto , Norihito Tokunaga , Mariko Hirozane
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: JP2016-019834 20160204
- Main IPC: C07D213/61
- IPC: C07D213/61 ; A61P25/00 ; C07D211/24 ; C07D211/36 ; C07D211/56 ; C07D213/30 ; C07D213/74 ; C07D213/75 ; C07D215/44 ; C07D401/06 ; C07D401/12 ; C07D401/14 ; C07D405/06 ; C07D405/12 ; C07D405/14 ; C07D409/06 ; C07D409/12 ; C07D413/06 ; C07D417/06 ; C07D417/14
Abstract:
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
Public/Granted literature
- US20240174610A1 SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF Public/Granted day:2024-05-30
Information query
